Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results
Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 an...
Stay updated with breaking news from Efficiency Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 an...
Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 and 70.3% from...
/PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide,...
Global Cannabis Net Revenue of $60.6 MillionAdjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022 Company Reaffirms Goal of Adj...
Global Cannabis Net Revenue of $60.6 Million Adjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022 Company Reaffirms Goal of Adjusted EBITDA...